[go: up one dir, main page]

DK95093D0 - Farmaceutisk formulering indeholdende et hormon - Google Patents

Farmaceutisk formulering indeholdende et hormon

Info

Publication number
DK95093D0
DK95093D0 DK93950A DK95093A DK95093D0 DK 95093 D0 DK95093 D0 DK 95093D0 DK 93950 A DK93950 A DK 93950A DK 95093 A DK95093 A DK 95093A DK 95093 D0 DK95093 D0 DK 95093D0
Authority
DK
Denmark
Prior art keywords
hormon
formula containing
pharmaceutical formula
pharmaceutical
formula
Prior art date
Application number
DK93950A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK93950A priority Critical patent/DK95093D0/da
Publication of DK95093D0 publication Critical patent/DK95093D0/da
Priority to CA002169840A priority patent/CA2169840A1/en
Priority to SK193-96A priority patent/SK19396A3/sk
Priority to KR1019960700847A priority patent/KR960703570A/ko
Priority to HU9600376A priority patent/HUT74167A/hu
Priority to CZ96425A priority patent/CZ42596A3/cs
Priority to BR9407306A priority patent/BR9407306A/pt
Priority to CN94193573A priority patent/CN1132478A/zh
Priority to NZ271617A priority patent/NZ271617A/en
Priority to EP94925355A priority patent/EP0789560A1/en
Priority to JP7507271A priority patent/JPH09501682A/ja
Priority to PL94313113A priority patent/PL313113A1/xx
Priority to PCT/DK1994/000310 priority patent/WO1995005807A1/en
Priority to AU75305/94A priority patent/AU7530594A/en
Priority to LT96-010A priority patent/LT4043B/lt
Priority to FI960749A priority patent/FI960749A0/fi
Priority to NO960653A priority patent/NO960653D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK93950A 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon DK95093D0 (da)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon
AU75305/94A AU7530594A (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progresterone and a polyethyelene glycol together with an excipient
BR9407306A BR9407306A (pt) 1993-08-20 1994-08-19 Composição farmacêutica para a administação oral e processo para preparar a mesma
NZ271617A NZ271617A (en) 1993-08-20 1994-08-19 Oral pharmaceutical composition comprising micronized progesterone, poly ethylene glycol and a starch, cellulose pectin or tragacanth excipient
KR1019960700847A KR960703570A (ko) 1993-08-20 1994-08-19 부형제와 함께 프로게스테론 및 폴리에틸렌글리콜을 함유하는 경구투여용 신규약제(a novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together wtth an excipient)
HU9600376A HUT74167A (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol
CZ96425A CZ42596A3 (en) 1993-08-20 1994-08-19 Pharmaceutical composition for oral administration containing micro milled prgesterone and polyethylene glycol together with en excipient and process for preparing thereof
CA002169840A CA2169840A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient
CN94193573A CN1132478A (zh) 1993-08-20 1994-08-19 含有孕酮、聚乙二醇及赋形剂的口服用新药物
SK193-96A SK19396A3 (en) 1993-08-20 1994-08-19 Pharmaceutical composition for oral administration comprising micronized progesterone and a polyethyelene glycol together with an excipient and producing method of this composition
EP94925355A EP0789560A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progresterone and a polyethyelene glycol together with an excipient
JP7507271A JPH09501682A (ja) 1993-08-20 1994-08-19 プロゲステロンおよびポリエチレングリコール並びに賦形剤を含んでなる経口投与用新規医薬組成物
PL94313113A PL313113A1 (en) 1993-08-20 1994-08-19 Novel pharmaceutical agent for oral administration containing progesterone and polyethylene glycol
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient
LT96-010A LT4043B (en) 1993-08-20 1996-02-15 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient
FI960749A FI960749A0 (fi) 1993-08-20 1996-02-19 Uusi suun kautta nautittava farmaseuttinen aine, joka sisältää keltarauhashormonia ja polyetyleeniglykolia yhdessä kantoaineen kanssa
NO960653A NO960653D0 (no) 1993-08-20 1996-02-19 Nytt, farmasöytisk middel for oral administrering omfattende progesteron og en polyetylenglykol sammen med en eksipiens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon

Publications (1)

Publication Number Publication Date
DK95093D0 true DK95093D0 (da) 1993-08-20

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon

Country Status (17)

Country Link
EP (1) EP0789560A1 (da)
JP (1) JPH09501682A (da)
KR (1) KR960703570A (da)
CN (1) CN1132478A (da)
AU (1) AU7530594A (da)
BR (1) BR9407306A (da)
CA (1) CA2169840A1 (da)
CZ (1) CZ42596A3 (da)
DK (1) DK95093D0 (da)
FI (1) FI960749A0 (da)
HU (1) HUT74167A (da)
LT (1) LT4043B (da)
NO (1) NO960653D0 (da)
NZ (1) NZ271617A (da)
PL (1) PL313113A1 (da)
SK (1) SK19396A3 (da)
WO (1) WO1995005807A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
BR0014159A (pt) * 1999-08-31 2002-05-07 Schering Ag Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768L (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
WO2003077923A1 (en) * 2002-03-14 2003-09-25 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
BRPI0409860A (pt) * 2003-04-29 2006-05-16 Akzo Nobel Nv processo de solidificação anti-solvente
CN101166521A (zh) 2005-04-28 2008-04-23 惠氏公司 通过湿制粒法制备包含微粒化他那普戈特的组合物
AT12800U1 (de) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド １７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
PL313113A1 (en) 1996-06-10
WO1995005807A1 (en) 1995-03-02
AU7530594A (en) 1995-03-21
CZ42596A3 (en) 1996-06-12
SK19396A3 (en) 1997-03-05
NZ271617A (en) 1996-11-26
KR960703570A (ko) 1996-08-31
CA2169840A1 (en) 1995-03-02
LT96010A (da) 1996-06-25
NO960653L (no) 1996-02-19
HU9600376D0 (en) 1996-04-29
HUT74167A (en) 1996-11-28
CN1132478A (zh) 1996-10-02
LT4043B (en) 1996-09-25
JPH09501682A (ja) 1997-02-18
BR9407306A (pt) 1996-10-08
NO960653D0 (no) 1996-02-19
EP0789560A1 (en) 1997-08-20
FI960749L (fi) 1996-02-19
FI960749A0 (fi) 1996-02-19

Similar Documents

Publication Publication Date Title
DK95093D0 (da) Farmaceutisk formulering indeholdende et hormon
FI921060L (fi) Farmaceutiska aerosolformuleringar
FI951098L (fi) Farmaseuttinen pakkaus
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
NO942923L (no) Medikamenter
DK0441643T3 (da) Inhaleringsapparat
DE69316010D1 (de) Anzeige
FI930882A (fi) Farmaceutiska foereningar
FI924456L (fi) Laekemedel
DE69314411D1 (de) Schalter
DE69315384D1 (de) Schalter
DE69306691D1 (de) Schalter
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A0 (fi) Farmaceutiska foereningar
NO943112D0 (no) Inkontinensbeskyttelse
ITMI913318A1 (it) Preparazioni farmaceutiche a liberazione programmata
DK138592D0 (da) Tabletter
FI93195C (fi) Säiliörakenne
DE59307150D1 (de) Display
DE69027594D1 (de) Ein thiazindioxidderivat enthaltendes medikament
DK136492D0 (da) A pharmaceutical formulation
DK110494A (da) Målekapseltæller
DK110892A (da) Et vindstop
ES1017558Y (es) Un display
BR7200437U (pt) Disposicao proporcionada a arandeia

Legal Events

Date Code Title Description
A0 Application filed
AHS Application shelved for other reasons than non-payment